Omega-3 Fatty Acid Based Nanolipid Formulation of Atorvastatin for Treating Hyperlipidemia
Purpose: In the current study, attempts have been made to formulate an omega-3 fatty acid based nanostructured lipid carriers of atorvastatin (AT), for treating hyperlipidemia; and to evaluate their antihyperlipidemic activity using in vitro and in vivo studies. Methods: Omega-3 fatty acid based AT...
Main Authors: | Revathy Sreedhar, Vrinda Sasi Kumar, Anil Kumar Bhaskaran Pillai, Sabitha Mangalathillam |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2019-06-01
|
Series: | Advanced Pharmaceutical Bulletin |
Subjects: | |
Online Access: | https://apb.tbzmed.ac.ir/PDF/apb-24203 |
Similar Items
-
EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01) -
A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia
by: Meenakshi Lella, et al.
Published: (2013-01-01) -
COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA
by: Safina Shabbir, et al.
Published: (2020-12-01) -
Elevated Interleukin-38 Level Associates with Clinical Response to Atorvastatin in Patients with Hyperlipidemia
by: Ning Yang, et al.
Published: (2018-08-01) -
Evaluation of periodontal health in patients taking atorvastatin
by: Kosar Rezaei Talarposhti, et al.
Published: (2018-09-01)